Amit Dilip Munshi is an entrepreneur and businessperson who founded Johnson & Johnson, Kythera Biopharmaceuticals LLC, Nephrian, Inc. and Oxeia Biopharmaceuticals, Inc. and who has been at the head of 9 different companies. Mr. Munshi is Chairman of Cytrellis Biosystems, Inc., Co-Chairman for Enterprise Therapeutics Ltd., Chairman of Galecto, Inc. and President, Chief Executive Officer & Director at Arena Pharmaceuticals, Inc., Chairman-Management Board at Arena Pharmaceuticals GmbH (a subsidiary of Arena Pharmaceuticals, Inc.). Amit Dilip Munshi is also on the board of 5 other companies.
In his past career he held the position of President & Chief Executive Officer for Percivia LLC, President, Chief Executive Officer & Director at EPIRUS Biopharmaceuticals, Inc. President, Chief Executive Officer & Director at Zalicus, Inc. and Chief Executive Officer for EPIRUS Biopharmaceuticals, Inc. (both are subsidiaries of EPIRUS Biopharmaceuticals, Inc.), General Manager-Nephrology Europe at Amgen, Inc., Chief Business Officer for Johnson & Johnson and Principal at Iolab Corp. (a subsidiary of Johnson & Johnson), Chief Business Officer of Kythera Biopharmaceuticals LLC, Principal at Astra Merck, Inc. and Director at Nephrian, Inc.
He received an undergraduate degree from the University of California, Riverside and an MBA from Peter F Drucker & Masatoshi Ito Graduate School of Management.